Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A23254 | 23923370 | Trop Gastroenterol | Insulin resistance and metabolic syndrome in nonobese Indian patients with non-alcoholic fatty liver disease. | 2013 | Details |
A23255 | 23923077 | Int J Clin Exp Pathol | Effect of chronic psychosocial stress on nonalcoholic steatohepatitis in mice. | 2013 | Details |
A23256 | 23922565 | Hepat Mon | Association of Adiponectin rs1501299 and rs266729 Gene Polymorphisms With Nonalcoholic Fatty Liver Disease. | 2013 | Details |
A23257 | 23922564 | Hepat Mon | Non alcoholic fatty liver disease in southern Iran: a population based study. | 2013 | Details |
A23258 | 23922466 | World J Gastroenterol | Garcinia Cambogia attenuates diet-induced adiposity but exacerbates hepatic collagen accumulation and inflammation. | 2013 | Details |
A23259 | 23921844 | Eur J Gastroenterol Hepatol | Sonographic quantification of a hepato-renal index for the assessment of hepatic steatosis in comparison with 3T proton magnetic resonance spectroscopy. | 2014 | Details |
A23260 | 23920952 | Stud Health Technol Inform | Noninvasive diagnosis of nonalcoholic steatohepatitis disease based on clinical decision support system. | 2013 | Details |
A23261 | 23920043 | Mol Genet Metab | Mitochondrial DNA methylation as a next-generation biomarker and diagnostic tool. | 2013 | Details |
A23262 | 23920034 | Clin Gastroenterol Hepatol | Endoscopic duodenal-jejunal bypass liner rapidly improves plasma parameters of nonalcoholic fatty liver disease. | 2013 | Details |
A23263 | 23919592 | BMC Pediatr | Intra-abdominal fat is related to metabolic syndrome and non-alcoholic fat liver disease in obese youth. | 2013 | Details |
A23264 | 23917437 | Nutr Clin Pract | Pediatric nonalcoholic fatty liver disease. | 2013 | Details |
A23265 | 23916847 | Gastroenterology | Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease. | 2013 | Details |
A23266 | 23915136 | Thyroid | Thyroid hormone analogues: where do we stand in 2013? | 2013 | Details |
A23267 | 23915028 | Free Radic Res | Mitochondrial dysfunction in non-alcoholic fatty liver disease and insulin resistance: cause or consequence? | 2013 | Details |
A23268 | 23914227 | Hepat Mon | Estimation of diagnosis and treatment costs of non-alcoholic Fatty liver disease: a two-year observation. | 2013 | Details |
A23269 | 23913732 | Obesity (Silver Spring) | Comparison of in vivo effects of insulin on SREBP-1c activation and INSIG-1/2 in rat liver and human and rat adipose tissue. | 2013 | Details |
A23270 | 23913731 | Obesity (Silver Spring) | Adipocyte size is associated with NAFLD independent of obesity, fat distribution, and PNPLA3 genotype. | 2013 | Details |
A23272 | 23913408 | Hepatology | Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease. | 2013 | Details |
A23273 | 23909258 | Vnitr Lek | [Effects of GLP-1 (glucagon-like peptide 1) on liver]. | 2013 | Details |
A23274 | 23909257 | Vnitr Lek | [Liver disorders in diabetic patients]. | 2013 | Details |
A23275 | 23907039 | Int J Cardiol | RBBB is associated with an increased risk of NAFLD in young healthy individuals. | 2013 | Details |
A23276 | 23906870 | Exp Mol Pathol | Chemerin is highly expressed in hepatocytes and is induced in non-alcoholic steatohepatitis liver. | 2013 | Details |
A23277 | 23905917 | J Allergy Clin Immunol | Innate sensors of pathogen and stress: linking inflammation to obesity. | 2013 | Details |
A23278 | 23905912 | Exp Clin Transplant | Effect of ethnicity on liver transplant for hepatocellular carcinoma. | 2013 | Details |
A23279 | 23902132 | Metab Syndr Relat Disord | Gender difference in hepatic steatosis index and lipid accumulation product ability to predict incident metabolic syndrome in the historical cohort of the Brisighella Heart Study. | 2013 | Details |
A23280 | 23900558 | Dig Dis Sci | Fatty liver disease index: a simple screening tool to facilitate diagnosis of nonalcoholic fatty liver disease in the Chinese population. | 2013 | Details |
A23281 | 23900008 | Food Chem Toxicol | The inhibitory effect of black soybean on hepatic cholesterol accumulation in high cholesterol and high fat diet-induced non-alcoholic fatty liver disease. | 2013 | Details |
A23282 | 23899279 | Expert Rev Gastroenterol Hepatol | Interaction of type 2 diabetes and nonalcoholic fatty liver disease. | 2013 | Details |
A23283 | 23898557 | Acta Gastroenterol Belg | Treatment of non-alcoholic fatty liver disease: can we already face the epidemic? | 2013 | Details |
A23284 | 26405460 | Clin Lipidol | Oxidized metabolites of linoleic acid as biomarkers of liver injury in nonalcoholic steatohepatitis. | 2013 | Details |
A23285 | 26000142 | Auto Immun Highlights | Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis. | 2013 | Details |
A23286 | 23897284 | Nat Rev Gastroenterol Hepatol | NAFLD: Predictive value of ALT levels for NASH and advanced fibrosis. | 2013 | Details |
A23287 | 23897104 | Ann Clin Biochem | Plasma adiponectin is a more specific marker of fatty liver than a marker of metabolic syndrome in Japanese men. | 2013 | Details |
A23288 | 23896654 | Nutrients | Dietary omega-3 fatty acid deficiency and high fructose intake in the development of metabolic syndrome, brain metabolic abnormalities, and non-alcoholic fatty liver disease. | 2013 | Details |
A23289 | 23896376 | Biochimie | Ectopic lipid accumulation: A potential cause for metabolic disturbances and a contributor to the alteration of kidney function. | 2013 | Details |
A23290 | 23895854 | Nan Fang Yi Ke Da Xue Xue Bao | [Hepatocyte apoptosis and mitochondrial permeability transition pore opening in rats with nonalcoholic fatty liver]. | 2013 | Details |
A23291 | 23895155 | Am J Chin Med | Ligusticum chuanxiong prevents ovariectomy-induced liver and vascular damage in rats. | 2013 | Details |
A23292 | 23894677 | PLoS One | Vismodegib suppresses TRAIL-mediated liver injury in a mouse model of nonalcoholic steatohepatitis. | 2013 | Details |
A23293 | 23894275 | PLoS One | Multi-SNP analysis of GWAS data identifies pathways associated with nonalcoholic fatty liver disease. | 2013 | Details |
A23294 | 23891824 | Gene | Peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms in nonalcoholic fatty liver disease: a study in Brazilian patients. | 2013 | Details |
A23295 | 23891820 | Gene | Association between the Pro12Ala polymorphism of PPAR-γ gene and the non-alcoholic fatty liver disease: a meta-analysis. | 2013 | Details |
A23297 | 23889731 | Expert Opin Investig Drugs | Statins and nonalcoholic fatty liver disease: a bright future? | 2013 | Details |
A23298 | 23886860 | Am J Physiol Gastrointest Liver Physiol | Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment. | 2013 | Details |
A23300 | 23885277 | Hepat Mon | Probiotics as a novel treatment for non-alcoholic Fatty liver disease; a systematic review on the current evidences. | 2013 | Details |
A23302 | 23884827 | Eur Rev Med Pharmacol Sci | Role of insulin resistance and adipocytokines on serum alanine aminotransferase in obese patients with type 2 diabetes mellitus. | 2013 | Details |
A23303 | 23883694 | J Nutr Sci Vitaminol (Tokyo) | The effect of ethyl pyruvate supplementation on rat fatty liver induced by a high-fat diet. | 2013 | Details |
A23304 | 23880173 | Mitochondrion | Modulation of hepatic redox status and mitochondrial metabolism by exercise: therapeutic strategy for liver diseases. | 2013 | Details |
A23305 | 23880135 | Curr Opin Microbiol | Colonic bacterial metabolites and human health. | 2013 | Details |
A23306 | 23879722 | Curr Med Res Opin | Effect of tobacco smoking and smoking cessation on plasma lipoproteins and associated major cardiovascular risk factors: a narrative review. | 2013 | Details |
A23308 | 23876851 | Semin Cancer Biol | Obesity, insulin resistance, NASH and hepatocellular carcinoma. | 2013 | Details |
A23309 | 23875831 | BMC Gastroenterol | The FLS (fatty liver Shionogi) mouse reveals local expressions of lipocalin-2, CXCL1 and CXCL9 in the liver with non-alcoholic steatohepatitis. | 2013 | Details |
A23310 | 23875703 | Clin Sci (Lond) | Involvement of the HIF-1α and Wnt/β-catenin pathways in the protective effects of losartan on fatty liver graft with ischaemia/reperfusion injury. | 2014 | Details |
A23311 | 23855304 | J Gastroenterol Hepatol | Family with sequence similarity 3 gene family and nonalcoholic fatty liver disease. | 2013 | Details |
A23312 | 23855302 | J Gastroenterol Hepatol | Differences in innate immune signaling between alcoholic and non-alcoholic steatohepatitis. | 2013 | Details |
A23313 | 23855299 | J Gastroenterol Hepatol | Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches. | 2013 | Details |
A23314 | 23855298 | J Gastroenterol Hepatol | Sterile inflammation in the liver and pancreas. | 2013 | Details |
A23315 | 23855294 | J Gastroenterol Hepatol | Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis. | 2013 | Details |
A23316 | 23855293 | J Gastroenterol Hepatol | Retinoids and their target genes in liver functions and diseases. | 2013 | Details |
A23317 | 23855290 | J Gastroenterol Hepatol | Epidemiology of alcoholic and nonalcoholic fatty liver disease in China. | 2013 | Details |
A23318 | 23874824 | PLoS One | Incidence of liver damage of uncertain origin in HIV patients not co-infected with HCV/HBV. | 2013 | Details |
A23319 | 23873346 | Curr Opin Clin Nutr Metab Care | The gut-liver axis. | 2013 | Details |
A23320 | 23872669 | Clin Gastroenterol Hepatol | Patatin-like phospholipase domain-containing protein 3 rs738409-G in recipients of liver transplants is a risk factor for graft steatosis. | 2013 | Details |
A23321 | 23872500 | Gastroenterology | No difference between high-fructose and high-glucose diets on liver triacylglycerol or biochemistry in healthy overweight men. | 2013 | Details |
A23322 | 23871755 | Free Radic Biol Med | MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases. | 2013 | Details |
A23323 | 23870935 | Food Chem | Effects of flavonoids from Rosa laevigata Michx fruit against high-fat diet-induced non-alcoholic fatty liver disease in rats. | 2013 | Details |
A23324 | 23870449 | BMC Pediatr | Pediatric non alcoholic fatty liver disease: more on novel treatment targets. | 2013 | Details |
A23325 | 23870067 | Liver Int | Role of FDFT1 polymorphism for fibrosis progression in patients with chronic hepatitis C. | 2013 | Details |
A23326 | 23869143 | J Hum Reprod Sci | Prevalence of hepatic steatosis in women with polycystic ovary syndrome. | 2013 | Details |
A23327 | 23868620 | Clin Ter | The treatment with ursodeoxycholic acid in elderly patients affected by NAFLD and metabolic syndrome: a case-control study. | 2014 | Details |
A23328 | 23868409 | Am J Physiol Gastrointest Liver Physiol | Reduced thoracic fluid content in early-stage primary biliary cirrhosis that associates with impaired cardiac inotropy. | 2013 | Details |
A23329 | 23867551 | Pharmacology | Expression of cytochrome P450 2A5 in a C57BL/6J mouse model of nonalcoholic fatty liver disease. | 2013 | Details |
A23330 | 23867312 | J Hepatol | Hepatic menin recruits SIRT1 to control liver steatosis through histone deacetylation. | 2013 | Details |
A23331 | 23866299 | Fibrogenesis Tissue Repair | Non-alcoholic fatty liver disease (NAFLD): a tale of fat and sugar? | 2013 | Details |
A23332 | 23865141 | J Pak Med Assoc | Are we ready for a new epidemic of under recognized liver disease in South Asia especially in Pakistan? Non alcoholic fatty liver disease. | 2013 | Details |
A23333 | 23864802 | Korean J Intern Med | Effects of D-002, a mixture of high molecular weight beeswax alcohols, on patients with nonalcoholic fatty liver disease. | 2013 | Details |
A23334 | 23862644 | Annu Rev Nutr | Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease. | 2013 | Details |
A23335 | 23861927 | PLoS One | Effects of sodium butyrate and its synthetic amide derivative on liver inflammation and glucose tolerance in an animal model of steatosis induced by high fat diet. | 2013 | Details |
A23336 | 23861709 | Evid Based Complement Alternat Med | Garlic-Derived S-Allylmercaptocysteine Ameliorates Nonalcoholic Fatty Liver Disease in a Rat Model through Inhibition of Apoptosis and Enhancing Autophagy. | 2013 | Details |
A23337 | 23861375 | Endocrinology | High-fat intake during pregnancy and lactation exacerbates high-fat diet-induced complications in male offspring in mice. | 2013 | Details |
A23338 | 23861108 | Dig Dis Sci | Betaine protects against high-fat-diet-induced liver injury by inhibition of high-mobility group box 1 and Toll-like receptor 4 expression in rats. | 2013 | Details |
A23339 | 23860502 | Gastroenterology | Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease. | 2013 | Details |
A23340 | 23860122 | Am J Physiol Endocrinol Metab | MLK3 promotes metabolic dysfunction induced by saturated fatty acid-enriched diet. | 2013 | Details |
A23341 | 23859493 | J Dig Dis | Performance of transient elastography (TE) and factors associated with discordance in non-alcoholic fatty liver disease. | 2013 | Details |
A23342 | 23858556 | Hepatogastroenterology | Blood urea nitrogen is elevated in patients with non-alcoholic fatty liver disease. | 2013 | Details |
A23343 | 23856494 | Food Chem Toxicol | Glutathione defense mechanism in liver injury: insights from animal models. | 2013 | Details |
A23344 | 23855271 | Appl Physiol Nutr Metab | Branched-chain amino acids alleviate nonalcoholic steatohepatitis in rats. | 2013 | Details |
A23345 | 23855267 | Appl Physiol Nutr Metab | Role of physical activity in the treatment of nonalcoholic fatty liver disease in children and adolescents. | 2013 | Details |
A23346 | 23853345 | Orv Hetil | [Non-alcoholic fatty liver disease and steatohepatitis]. | 2013 | Details |
A23348 | 23851679 | Food Funct | Oat β-glucan inhibits lipopolysaccharide-induced nonalcoholic steatohepatitis in mice. | 2013 | Details |
A23349 | 23850676 | Biochem Biophys Res Commun | Propranolol, a β-adrenoceptor antagonist, worsens liver injury in a model of non-alcoholic steatohepatitis. | 2013 | Details |
A23350 | 23850511 | Gastroenterol Hepatol | [Liver enzymes elevation: etiologic study and efficiency of a single-act office visit]. | 2013 | Details |
A23352 | 23849554 | Nurs Outlook | Exploration of a symptoms experience in people with obesity-related nonalcoholic fatty liver disease. | 2014 | Details |
A23353 | 23848366 | Expert Opin Emerg Drugs | Emerging drugs for non-alcoholic steatohepatitis. | 2013 | Details |
A23354 | 23847661 | Arch Med Sci | Statins and cardiovascular outcomes in elderly and younger patients with coronary artery disease: a post hoc analysis of the GREACE study. | 2013 | Details |
A23356 | 23845075 | Curr Diabetes Rev | The influence of diabetes in the pathogenesis and the clinical course of hepatocellular carcinoma: recent findings and new perspectives. | 2013 | Details |
A23357 | 23844815 | Curr Pharm Des | Nonalcoholic fatty liver disease and cardiovascular disease. | 2014 | Details |
A23358 | 23843938 | PLoS One | Liver fat content, evaluated through semi-quantitative ultrasound measurement, is associated with impaired glucose profiles: a community-based study in Chinese. | 2013 | Details |
A23359 | 23843872 | Evid Based Complement Alternat Med | Update on berberine in nonalcoholic Fatty liver disease. | 2013 | Details |
A23360 | 23843692 | Drug Des Devel Ther | S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis. | 2013 | Details |
A23362 | 23843206 | Hepatology | Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease. | 2013 | Details |